Market review: Moderna gains on vaccine trial results

November 21, 2020 at 8:00PM
Biotechnology company Moderna got a 10.5% stock price bump on promising news of its vaccine.
Biotechnology company Moderna got a 10.5% stock price bump on promising news of its vaccine. (Chandan Khanna • AFP via Getty Images/The Minnesota Star Tribune)

Vaccine bounce

Moderna shares rose 10.5% to $98.79 Monday after reporting its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial. Shares closed Friday at $97.61.

Disruption

CVS Health fell 8.4% to $67.32 and Walgreens Boots Alliance declined 9.1% to $40.10 as investors fled pharmacy stocks Tuesday after Amazon opened an online pharmacy that allows customers to have prescriptions delivered to their door in a couple of days. CVS finished the week at $66.39.; Walgreens closed Friday at $37.53.

Rising costs

Lowe's Cos dropped 8.1% to $146.86 Wednesday after third-quarter earnings missed analysts' expectations on rising expenses due to store revamps and COVID-19 costs. Shares closed Friday at $149.93.

Bigger things ahead

Tesla shares rose 10.2% to $486.64 Wednesday after Morgan Stanley gave the stock an overweight rating, predicting a "profound model shift" as the company shifts from selling cars to generating high-margin software and services revenue. Shares closed Friday at $489.61.

Earnings bounce

L Brands, the company behind Bath & Body Works and Victoria's Secret, rose 16.5% to $39.15 Thursday after reporting profit for the latest quarter that blew past Wall Street's expectations. Shares closed Friday at $39.97.

Sweet music

Sonos rose 28.1% to $21.90 Thursday as a bigger-than-expected surge in sales of its audio products in its most recent quarter showed consumers continue to spend on items to spruce up their homes. Shares closed the week at $20.94.

News Services

about the writer

about the writer

More from Business

See More
card image
Fairview Health Services

The school is changing an elective course while still working with the Eden Prairie-based health care giant after students raised concerns.

This transmission electron microscope image shows SARS-CoV-2, the virus that causes COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in the lab. (NIAID/TNS) ORG XMIT: 1659810
card image